Showing results (461-470 of 482) with videos related to

Sort By:
Pageof 49
JAMA|May 4, 2021
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical TrialSiri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al.
Journal of Crohn'S & Colitis|June 6, 2023
Fatigue in Patients with Newly Diagnosed Inflammatory Bowel Disease: Results from a Prospective Inception Cohort, the IBSEN III StudyKristina I Aass Holten, Tomm Bernklev, Randi Opheim, et al.
Annals of the Rheumatic Diseases|December 17, 2013
Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritisMarthe T Maehlen, Inge C Olsen, Bettina K Andreassen, et al.
Journal of Crohn'S & Colitis|March 13, 2026
Anxiety and depression in newly diagnosed patients with inflammatory bowel disease (the IBSEN III study) compared with the general population in NorwayIngunn Johansen, Milada C Hagen, Stine T Løkkeberg, et al.
The Lancet. Rheumatology|April 7, 2024
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trialKaja E Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al.
Journal of the Neurological Sciences|March 22, 2017
Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric populationTheresa Bourne, Michael Waltz, T C Casper, et al.
Cell Reports|November 8, 2018
A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human PrimatesJennifer R Keeffe, Koen K A Van Rompay, Priscilla C Olsen, et al.
Journal of Leukocyte Biology|September 15, 2024
The Escherichia coli TolC efflux pump protein is immunogenic and elicits protective antibodiesThaynara O Silva, Bárbara A Teixeira, Leon V S Costa, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 23, 2020
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension TrialsKristin K Jørgensen, Guro L Goll, Joe Sexton, et al.
American Journal of Respiratory and Critical Care Medicine|December 15, 2020
Secretory Cells Dominate Airway CFTR Expression and Function in Human Airway Superficial EpitheliaKenichi Okuda, Hong Dang, Yoshihiko Kobayashi, et al.
Pageof 49